Molecular docking: Hydroxychloroquine alternative to inhibit the COVID-19 main protease (MPro)
收藏DataCite Commons2020-08-25 更新2024-07-28 收录
下载链接：
https://figshare.com/articles/Molecular_docking_study_on_the_structure_of_COVID-19_main_protease_MPro_to_find_the_best_viral_iinhibitor/12032745/26
下载链接
链接失效反馈官方服务：
资源简介：
Docking study shows best binding affinity against the main protease of COVID-19. As per the docking results top twelve compounds as a MPro inhibitor, Coumermycin A1 (-10.2), Irinotecan (-9.4), Suramin (-9.4), Trovafloxacin (-9.3), Aclarubicin (-9.0), Dactinomycin (-9.0), TG-100801 (-9.0), Raltegravir (-8.9), Digoxin (-8.9), Etoposide (-8.9), Doxorubicin (-8.8), and Venetoclax (-8.8) from the tested compounds.<br>Email ID: u105850009@kmu.edu.tw<br><br>ARULANANDAM, CHARLI DEEPAK (2020): Molecular docking: Hydroxychloroquine alternative to inhibit the COVID-19 main protease (MPro). figshare. Dataset. https://doi.org/10.6084/m9.figshare.12032745.v26
提供机构：
figshare
创建时间：
2020-04-07
